Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer

Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer

B.J. Amorim, V. Prabhu, S.S. Marco, D. Gervais, W.E. Palmer, P. Heidari, M. Vangel, P.J. Saylor, O.A. Catalano

ARTIGO

Inglês

Purpose: 18F-Fluciclovine is indicated for evaluation of suspected prostate cancer (PCa) biochemical recurrence. There are few studies investigating fluciclovine with PET/MR and none evaluated osseous metastases. Our aim was to assess the performance of 18F-fluciclovine PET/MR (fluciclovine-PET/MR)...

Fechado

Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer

B.J. Amorim, V. Prabhu, S.S. Marco, D. Gervais, W.E. Palmer, P. Heidari, M. Vangel, P.J. Saylor, O.A. Catalano


										

Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer

B.J. Amorim, V. Prabhu, S.S. Marco, D. Gervais, W.E. Palmer, P. Heidari, M. Vangel, P.J. Saylor, O.A. Catalano

    Fontes

    European journal of nuclear medicine and molecular imaging

    Vol. 47, no. 1 (Jan., 2020), p. 105-114